Flagship Wealth Advisors’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.94K Buy
+25
New +$3.95K ﹤0.01% 423

Other funds holding XBI

Flagship Wealth Advisors's XBI Position: Q3 2026 in Review

Flagship Wealth Advisors opened a new position in State Street SPDR S&P Biotech ETF (XBI) in Q3 2026: 25 shares worth $3.94K. The stake represents ﹤0.01% of the portfolio and ranks #423 among its holdings.

960 funds tracked by Wall St. Rank hold XBI as of Q3 2026.

  • Flagship Wealth Advisors held 25 shares of State Street SPDR S&P Biotech ETF worth $3.94K as of Q3 2026.
  • State Street SPDR S&P Biotech ETF was a new Flagship Wealth Advisors position in Q3 2026.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of Flagship Wealth Advisors's portfolio in Q3 2026, its #423 holding.
  • 960 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q3 2026.

Based on Flagship Wealth Advisors's 13F filing for Q3 2026, filed 3 Nov 2026.